Acetylcholinesterase Inhibitory Activity of Green Tea Polyphenols by Raghavendra, HL et al.
141 
 
A Peer-reviewed Official International Journal of Wollega University, Ethiopia 
 DOI: http://dx.doi.org/10.4314/star.v3i4.20  
 ISSN: 2226-7522(Print) and 2305-3372 (Online)  
Science, Technology and Arts Research Journal  
Sci. Technol. Arts Res. J., Oct-Dec 2014, 3(4): 141-142 





Acetylcholinesterase Inhibitory Activity of Green Tea Polyphenols 
 
 Raghavendra H.L1, Prashith Kekuda T.R2 and Farhath Khanum3*  
 
1
College of Medical and Health Sciences, Wollega University, Post Box No: 395, Nekemte, Ethiopia 
2
Post Graduate Department of Studies and Research in Microbiology, Sahyadri Science College 
(Autonomous), Kuvempu University, Shivamogga-577203, Karnataka, India 
3
Biochemistry and Nano Sciences Division, Defense Food Research Laboratory, Siddarthanagar,       
Mysore-570011, India 
 Abstract  Article Information 
Inhibition of acetylcholinesterase activity is one of the most popular approaches for 
treatment of neurological disorders such as Alzheimer’s disease and others. In the 
present study, we evaluated inhibition of acetylcholinesterase activity by different 
concentrations of green tea (Camellia sinensis L.) extract using acetylthiocholine as 
substrate. The green tea extract inhibited AChE activity dose dependently with an 
IC50 value of 42.05µg/ml. The observed inhibitory activity could be ascribed to the 
polyphenolic content of green tea extract. Consumption of green tea might provide 
protection against neurological disorders. 
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INTRODUCTION 
Acetylcholine is a neurotransmitter which plays a key 
role in memory and cognition. Acetylcholinesterase 
(AChE) is an enzyme that causes the termination of nerve 
impulse transmission at the cholinergic synapses by rapid 
hydrolysis of acetylcholine (ACh). Hence, inhibition of 
AChE is an important strategy for the treatment of 
neurological disorders such as Alzheimer’s disease, 
senile dementia, ataxia, myasthenia gravis and 
Parkinson’s disease. Drugs such as tacrine, donepezil, 
and rivastigmine have been used to treat cognitive 
dysfunction and memory loss associated with Alzheimer’s 
disease. These drugs have shown to slow down 
neurodegeneration process. However, these compounds 
have adverse effects including gastrointestinal 
disturbances and problems associated with bioavailability. 
This necessitates an immense interest in searching better 
AChE inhibitors from natural resources. 
Ethnopharmacological studies and bioassay-guided 
isolation have provided a lead in identifying novel and 
potent AChE inhibitors from plants (Mukherjee et al., 
2007; Ohran et al., 2008; Lu et al., 2011).  
 
Tea (Camellia sinensis L., family Theaceae) is one of 
the most popular beverages consumed all over the world. 
It is consumed as green, black, or Oolong tea. Among 
these, significant effects on human health have been 
observed with the consumption of green tea. Green tea is 
manufactured by drying fresh tea leaves. Green tea is 
non-fermented and the beneficial effects of green tea are 
mainly due to its polyphenols which may account for up to 
30% of dry weight. Catechin is the one of the most 
important phenolic constituent of green tea. Green tea 
extract and its components have shown to exhibit 
activities such as anticancer, hepatoprotective, 
antimicrobial, antioxidant, neuroprotective and others 
(Cabrera et al., 2006; Chacko et al., 2010; Jo et al., 2012).  
In our previous study, we have undertaken an extraction 
and examination of chemical constituents of green tea for 
its in vitro antioxidant activity (Raghavendra et al., 2011). 
The present study focused on the AChE inhibitory activity 
of green tea extract.   
 
MATERIALS AND METHODS 
Chemicals  
Electric eel AChE, Acetylthiocholine iodide and 5-5’-
thiobis-2-nitrobenzoic acid (DTNB) were purchased from 
Sigma (USA). Eserine was obtained from Merck 
(Germany). All other reagents were of analytical grade. 
 
Preparation of Green Tea Extract 
Green tea extract was prepared by following the 
methodology employed in our previous study 
(Raghavendra et al., 2011). The green tea extract at 
different concentrations (1-100µg/ml) was used to screen 
AChE inhibitory activity. 
 
AChE Inhibition Assay 
AChE inhibition assay of the green tea extract was 
carried out according to the method of Orhan et al. (2007) 
with some modifications. Here, 250µl of extract/standard 
of various concentrations in 200mM phosphate buffer (pH 
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7.7), 80µl of DTNB (3.96mg of DTNB and 1.5mg sodium 
bicarbonate dissolved in 10ml phosphate buffer pH 7.7) 
and 10µl of enzyme (2U/ml) was incubated at 25
o
C for 
5min. After incubation, 15µl of the substrate 
(acetylthiocholine iodide: 10.85mg in 5ml of phosphate 
buffer) was added and incubated again for 5min. The 
color so developed was measured in a microwell plate 
reader at 412nm (Versamax, Molecular Devices, 
Sunnyvale, USA). The percent inhibition was calculated 
using the formula: 
 
AChE inhibitory activity (%) = (Ac - At / Ac) × 100, 
where Ac is absorbance of control and At is absorbance 
of test. Eserine hemisulphate was used as the standard 
drug.   
 
Statistical Analysis 
The extract and standard were assayed in triplicate 
and the result was recorded as Mean inhibition (M.I) ± 
Standard deviation (S.D). The IC50 (Inhibitory 




The results of the AChE inhibitory activity of green tea 
extract and standard were depicted in Table 1. Green tea 
extract showed 66.46±1.38 % of AChE inhibitory activity 
at 100µg/ml concentration and Eserine hemisulphate 
showed 93.87±0.96% of in inhibitory activity at 0.25µg/m. 
IC50 value of green tea extract and standard was 42.05 
and 0.02µg/ml respectively.   
 
Table 1:  AChE inhibitory activity of Green tea extract and 























MI: Mean % inhibition; S.D: Standard Deviation 
 
DISCUSSION 
It is forecasted that 5% of the global population will be 
aged 85 years or over by 2034 and it inevitably lead to an 
increase in age-associated disorders such as Alzheimer's 
disease (Okello et al., 2012). Alzheimer’s disease is one 
of the neurodegenerative disorders resulted by the loss of 
cholinergic neuromediators in the brain and enhanced 
AChE activity. This disease is the most common cause of 
dementia leading to the loss of intellectual and social 
abilities severe enough to interfere with daily functioning. 
The remarkable biochemical change which can be seen in 
neurodegenerative diseases is the reduction of ACh levels 
in the hippocampus and cortex of the brain. Therefore, 
inhibition of AChE is presently the most established 
approach to treating Alzheimer’s disease (Ohran et al., 
2008; Okello et al., 2012).  
 
There is high evidence that green tea exhibits a number of 
health-promoting effects. It may beneficial potentially to 
those suffering from neurodegenerative diseases, 
cardiovascular disease and cancer. The beneficial effects 
of green tea are mainly attributed to the high polyphenol 
content in particular catechins (Okello et al., 2012). In the 
present study, we evaluated AchE inhibitory activity of 
green tea extract. AChE hydrolyses ACh to give 
thiocholine and acetate. The reaction between thiocholine 
and DNBT gives 2-nitro-5-mercaptobenzoate, a yellow 
compound which is measured at 412 nm. The green tea 
extract exhibited dose dependent inhibition of AchE 
activity with an IC50 value of 42.05µg/ml. It has been 
shown earlier that white and green tea extract and purified 
tea compounds exhibit AChE inhibitory activity (Okello et 
al., 2012).  The seed and pericarp of tea were shown to 
possess AChE inhibitory activity (Jo et al., 2012). 
 
CONCLUSION 
The experimental data obtained from the present 
study showed that green tea extract exhibit potent in vitro 
AChE inhibition activity. The further in vivo research is 
undertaken in order to study the exact mechanism of 
action of green tea polyphenols.   
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